Jan. 26, 2023—Vanderbilt researchers are inviting non-health care essential workers to participate in a study to better understand how they continue to be impacted by COVID-19.
Jan. 19, 2023—Vanderbilt's Emerging Infections Program (EIP) recently received the Toby Merlin Award for Excellence in Emergency Response, presented by the Centers for Disease Control and Prevention (CDC) and the Agency for Toxic Substances and Disease Registry.
Dec. 21, 2022—Flu season came a month early this year in Tennessee and hit hard, disproportionately affecting children, according to Epidemic Intelligence Service (EIS) data gathered by the Centers for Disease Control and Prevention (CDC), Tennessee Department of Health and Vanderbilt University Medical Center.
Monroe Carell Jr. Children’s Hospital at Vanderbilt/CDC investigate mysterious liver disease in children
Apr. 26, 2022—Physicians at Monroe Carell Jr. Children’s Hospital at Vanderbilt are collaborating with the CDC and other hepatologists around the country to help figure out the origins of a mysterious liver disease affecting children ages 1 month to 16 years old.
Feb. 9, 2022—Vanderbilt research shows that two doses of an mRNA COVID-19 vaccine result in lower effectiveness for preventing hospitalization for the omicron variant than previous variants. However, importantly, a third (“booster”) vaccine dose significantly improves protection against omicron hospitalization up to 86%.